COVID-19 Q&A Webinar
Dr Lizzy MacPhie and Dr Marwan Bukhari discuss the British Society for Rheumatology's COVID-19 rheumatology guidance in this webinar.
COVID-19 Update Webinar presented by IMG's Dr. Geoff Tothill 12-18-2020
IMG's Chief Medical Officer, Dr. Geoff Tothilll, presents a live webinar about the current coronavirus pandemic including the COVID-19 vaccines.
Session 1: The Science of COVID-19 | Global Science Summit on COVID-19
Discussion about the virus SARS-CoV-2 and the disease it causes, COVID-19.
Carnival Corporation, in collaboration with WTTC, hosted a selection of the world’s leading scientists and medical experts for an in-depth summit on COVID-19.
A combination of science-based discussions sharing the latest knowledge of key topic areas, speakers examined the epidemiology of the virus, transmission, testing, prevention, treatments, vaccines and approaches to help mitigate and live with COVID-19.
Our panellists included the following leading experts:
• Dr Steven Gordon - Chairman of the Department of Infectious Disease, Cleveland Clinic Respiratory Institute
• Dr William Morice - Chair, Department of Laboratory Medicine and Pathology at Mayo Clinic, President, Mayo Clinic Laboratories, and Professor
• Dr Julio Frenk - President of University of Miami
• Dr Jewel Mullen - Associate Dean for Health Equity at the Dell Medical School
• Dr Vivek Murthy - Author & Former Vice Admiral in the Public Health Service Commissioned Corp
• Dr Adolfo Garcia-Sastre - Co-Director of the Global Health & Emerging Pathogens Institute at The Icahn School of Medicine
• Dr Michael Rosbash - 2017 Nobel Laureate in Physiology or Medicine
• Dr Thomas J. Cahill - Founder and Managing Partner of Newpath Management
• Dr Michael Z. Lin - Associate Professor of Neurobiology, Bioengineering and Chemical and Systems Biology at Stanford University
Copyright © Carnival Corporation and World Travel & Tourism Council.
Any reproduction without Carnival Corporation and World Travel & Tourism Council's written consent or illegal distribution of the content in any form will result in immediate action against the person/companies concerned.
The Challenges of Drug Development During COVID-19
The College of Computer and Mathematical and Natural Sciences in collaboration with the University of Maryland Alumni Association presents the 2020 Robert E. Fischell Virtual Lecture, featuring Dr. Merdad Parsey '85, Chief Medical Officer at Gilead Sciences.
Dr. Parsey will discuss Gilead Sciences' efforts to quickly develop therapeutics to treat COVID-19, including the scientific, ethical and logistical challenges. He will also describe the challenges the company has faced in developing other therapeutics during the pandemic, e.g., difficulties in treating patients during shelter-in-place orders and remote patient safety monitoring.
Merdad Parsey, M.D., Ph.D., is Gilead's Chief Medical Officer, responsible for overseeing the company's global clinical development and medical affairs organizations. In his role, Parsey supervises all clinical trials and development operations. Together with the leadership team, he works to advance clinical development strategies and programs with the goal of changing the trajectory of disease, and transforming care for the patients of today and tomorrow. Parsey joined Gilead in 2019, after serving as Senior Vice President of Early Clinical Development at Genentech, where he led clinical development for areas including inflammation, oncology and infectious diseases. Prior to Genentech, Parsey served as President and CEO of 3-V Biosciences (now Sagimet BioSciences), held development roles at Sepracor, Regeneron and Merck and was Assistant Professor of Medicine and Director of Critical Care Medicine at the New York University School of Medicine. Parsey currently serves on the Board of Directors for Sagimet BioSciences. He completed his B.S. in microbiology and biochemistry at the University of Maryland, College Park in 1985; his M.D. and Ph.D. at the University of Maryland, Baltimore; his residency in internal medicine at Stanford University; and his fellowship in pulmonary and critical care medicine at the University of Colorado.
Read a recent Q&A with Parsey and the CMNS communications team:
COVID-19 Panel Discussion
Chair: Nicholas Reich, University of Massachusetts, Amherst
Panel: P. Van Mieghem, Delft University of Technology; Aleksandr Aravkin, Institute for Health Metrics and Evaluation; Ryan Tibshirani, Carnegie Mellon; Jurgen Doornik, Oxford University
COVID-19 and Cancer Virtual Expert Board | 11th May 2021
Program Coordinators - Dr Purvish Parikh, Dr TP Sahoo & Dr Amish Vora
COVID 19 and Cancer Virtual Expert Board | 25th May
Maintaining and Sustaining Breathing During and After COVID-19
Moderated by Dr Parthiv Mehta
D dimer, anticoagulants and COVID-19 in cancer patients
Moderated by Dr Amish Vora
The COVID-19 Vaccine: A Talk with the Experts
The pandemic has mobilized global science to rapidly find ways to protect against or control the coronavirus infection. The huge public health challenge has led to the interdisciplinary application of new technologies in the development of vaccines and antiviral agents.
New technologies include: genetic engineering in the development of new vaccines based on the DNA and RNA of viral proteins, and the in silico modeling of the crystal structures of key coronavirus enzymes (protease and polymerase) that control its proliferation in the host. This impacts the design and development of innovative vaccines and antiviral synthetic drugs.
The combination of biosciences with dynamic molecular modeling, artificial intelligence, and machine-learning will accelerate this process. The development of algorithms for the analysis of clinical and genetic data of hundreds of thousands of patients and carriers of the infection quickly provided significant knowledge about the behavior of the virus and subsequent treatment protocols. These technologies will help the constant genomic-molecular monitoring of the mutations of coronavirus, unraveling its preserved-non mutating viral regions for effectively updating vaccines and the antiviral monoclonal antibodies.
The Northeastern Greece Community invites you to a discussion on the COVID-19 vaccine and Northeastern's preventative initiatives, a timely event that will help broaden your knowledge during these challenging times.
Hear from David Luzzi, PhD, Vice President and Senior Vice Provost at Northeastern University and Achilleas Gravanis, Professor of Pharmacology at the University of Crete. The talk will be moderated by Peter Contis, MBA’83, MS’86, President of the Northeastern Greece Community.
Immunity: The age of post-COVID ingredients
In a post-COVID world, immunity has become a buzz word. We look at the latest trends in natural ingredients supporting immunity. Specifically, we look at the science and human clinical trial data on the newest botanicals for immune health. Using recent science based peer-reviewed papers, and innovations on botanical extraction methods, we take a deep-dive into the immune supporting ingredients and the structural/functional claims to be made for the food, beverage and nutraceutical verticals.
COVID-19 and Cancer Virtual Expert Board | 6th May 2021
Program Coordinators - Dr Purvish Parikh, Dr TP Sahoo & Dr Amish Vora
1) Summary of Consensus from 4th May - Moderated by Dr T P Sahoo
2) Role of CT Chest in COVID-19 (Society of Chest Imaging and Intervention Guidelines) - Talk by Dr Bhavin Jankharia
3) Chest Imaging, COVID-19 and Cancer - Moderated by Dr Ullas Batra
4) Proposed Agenda and Faculty for Session on 11th May - Moderated by Dr Purvish Parikh
Stroke and Heart Attack | Medical Care During COVID-19
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Visit our:
Website ▪
Facebook ▪
Follow us on:
Twitter ▪ @poconotourism
Instagram ▪ @poconotourism
COVID-19 | Situation Update | July 27
Watch this week's virtual situation update on #COVID19 as Medical Director, Dr Katherine O’Reilly and Security Director, Intelligence and Operations, James Bird, share the notable changes in the #pandemic including the latest on the vaccine development as well as a review of our #COVID19 impact scales. #businessresilience #ReturntoWork #businesscontinuity #returntotravel
COVID-19 Online International Conference 2020 Dr. Conzo china
COVID-19 Online International Conference 2020
National Webinar on COVID19 What YOU should and should NOT do
Covid 19 - Infection Control Management and Role of Vitamin- C
The webinar is featuring Dr.Kapil Zirpe and Dr.Shubhal Dixit.
They will be presenting on Infection Control Management of Covid-19 and Also Role of Vitamin C in COVID 19.
Paediatric CoVID 19 Infection
General information regarding Paediatric CoVID 19 Infection
Module 7 Video 2: Disability-Inclusive health during the COVID 19 Pandemic
Watching this video is Step 4 of Module 7 of the WHO Disability-Inclusive Health Services Training Package. The video discusses the specific challenges the COVID-19 pandemic presented for people with disability, and what can be done to ensure health responses to the pandemic are inclusive of people with disability.
The WHO Disability-Inclusive Health Services Training Package is a companion to the “WHO Disability-Inclusive Health Services Toolkit: A resource for health facilities in the Western Pacific Region”. The package offers a range of training materials, including a presentation, workbook, and videos. Together, these help people develop foundational skills and understanding needed to ensure equitable access to health services and improve health outcomes for all people with disability. For more information see
The clinical signs and symptoms of the new coronavirus.
COVID-19 Update, March 27, 2020, Interview with Dr. Brian Artman of Legacy Mt. Hood Medical Center
Mayor Shane Bemis interviews a local medical expert, Dr. Brian Artman, the Medical Director at the Emergency Department at Legacy Mount Hood Medical Center. How can the community best help frontline medical personnel during the Covid-19 pandemic? What should Gresham residents know about how this virus spreads, and how best can they help reduce the spread of the virus? What is Legacy Mt. Hood doing to prepare for a potential of a surge in patients? Dr. Artman provides the answers.
South Africa COVID outbreak: 'Mild cases' of Omicron infection reported
A South African doctor who raised the alarm about the new variant of the coronavirus says her patients who have been diagnosed with the Omicron variant have shown mainly mild symptoms so far.
Al Jazeera's Fahmida Miller reports from Johannesburg, South Africa.
@aljazeeraenglish
@ Fahmida Miller
- Follow us on Twitter:
- Find us on Facebook:
- Check our website:
#AlJazeeraEnglish
#OMNICRON
#Covid-19